← Back to Search

Artificial Intelligence

AI Noise Reduction for Hearing Loss

N/A
Recruiting
Led By Aniket Saoji, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if using artificial intelligence to reduce background noise can help people with hearing loss hear and understand speech better.

Who is the study for?
This trial is for individuals with hearing impairment, whether they are new to using hearing aids or currently use them. It also includes those who have a cochlear implant in one ear and use a hearing aid in the other. People already satisfied with their current hearing aids or unable to follow the study protocol may not qualify.
What is being tested?
The trial is testing DEEPSONIC™, an AI-based noise reduction technology integrated into Phonak Hearing Aids. The goal is to see if this advanced feature can improve speech understanding and overall hearing in noisy environments compared to standard models.
What are the potential side effects?
Since this intervention involves non-invasive technology within hearing aids, side effects are minimal but could include discomfort from wearing the device, potential auditory fatigue or headaches from initial adjustment periods.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Sentence Testing
Single-word Testing

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Hearing Aid onlyExperimental Treatment1 Intervention
Patients with hearing impairment who do not have a Cochlear implant
Group II: Cochlear Implant with Hearing AidExperimental Treatment1 Intervention
Patients with hearing impairment who have a single-sided implant (using a hearing aid on the opposite ear)

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,360 Previous Clinical Trials
3,062,741 Total Patients Enrolled
6 Trials studying Hearing Loss
819 Patients Enrolled for Hearing Loss
Aniket Saoji, PhDPrincipal InvestigatorMayo Clinic
~333 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top